Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-25-047091
Filing Date
2025-03-28
Accepted
2025-03-28 20:20:41
Documents
1
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 3475
  Complete submission text file 0000950170-25-047091.txt   4946
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Issuer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1900 POWELL STREET SUITE 750 EMERYVILLE CA 94608
Business Address
Prentiss Christopher B (Reporting) CIK: 0001717583 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-50865 | Film No.: 25788385